Norinchukin Bank The Has $45.01 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Norinchukin Bank The grew its position in shares of The Clorox Company (NYSE:CLX) by 14.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 233,331 shares of the company’s stock after purchasing an additional 28,952 shares during the quarter. The Clorox makes up 0.6% of Norinchukin Bank The’s holdings, making the stock its 25th biggest holding. Norinchukin Bank The’s holdings in The Clorox were worth $45,005,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. AFT Forsyth & Company Inc. increased its stake in The Clorox by 1.8% in the 4th quarter. AFT Forsyth & Company Inc. now owns 3,075 shares of the company’s stock worth $621,000 after acquiring an additional 55 shares during the last quarter. One Day In July LLC boosted its holdings in shares of The Clorox by 3.3% in the 1st quarter. One Day In July LLC now owns 1,771 shares of the company’s stock worth $342,000 after purchasing an additional 57 shares in the last quarter. Associated Banc Corp boosted its holdings in shares of The Clorox by 4.5% in the 1st quarter. Associated Banc Corp now owns 1,330 shares of the company’s stock worth $230,000 after purchasing an additional 57 shares in the last quarter. Ziegler Capital Management LLC boosted its holdings in shares of The Clorox by 1.8% in the 4th quarter. Ziegler Capital Management LLC now owns 3,283 shares of the company’s stock worth $663,000 after purchasing an additional 59 shares in the last quarter. Finally, Syntal Capital Partners LLC boosted its holdings in shares of The Clorox by 0.9% in the 4th quarter. Syntal Capital Partners LLC now owns 6,682 shares of the company’s stock worth $1,349,000 after purchasing an additional 59 shares in the last quarter. 78.10% of the stock is currently owned by hedge funds and other institutional investors.

CLX stock traded up $1.39 on Thursday, reaching $177.09. 19,598 shares of the company traded hands, compared to its average volume of 1,608,776. The Clorox Company has a one year low of $175.25 and a one year high of $239.87. The company has a debt-to-equity ratio of 2.65, a quick ratio of 0.70 and a current ratio of 1.08. The company has a market cap of $22.03 billion, a P/E ratio of 24.50, a P/E/G ratio of 3.36 and a beta of 0.20. The firm’s fifty day simple moving average is $184.76.

The Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 29th. The company reported $1.62 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.48 by $0.14. The Clorox had a return on equity of 104.74% and a net margin of 12.27%. The company had revenue of $1.78 billion during the quarter, compared to analyst estimates of $1.86 billion. During the same quarter last year, the company earned $1.89 EPS. The firm’s revenue for the quarter was down .1% on a year-over-year basis. As a group, sell-side analysts forecast that The Clorox Company will post 7.59 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 13th. Investors of record on Wednesday, July 28th will be given a dividend of $1.16 per share. This represents a $4.64 dividend on an annualized basis and a yield of 2.62%. The ex-dividend date of this dividend is Tuesday, July 27th. This is a positive change from The Clorox’s previous quarterly dividend of $1.11. The Clorox’s dividend payout ratio (DPR) is 60.33%.

Several equities research analysts recently weighed in on the company. Jefferies Financial Group dropped their target price on The Clorox from $205.00 to $195.00 and set a “hold” rating for the company in a report on Tuesday, May 4th. Barclays reiterated a “sell” rating and issued a $162.00 price objective on shares of The Clorox in a report on Sunday, April 18th. Deutsche Bank Aktiengesellschaft dropped their price objective on The Clorox from $195.00 to $186.00 and set a “hold” rating for the company in a report on Monday, May 3rd. JPMorgan Chase & Co. dropped their price objective on The Clorox from $205.00 to $196.00 and set a “neutral” rating for the company in a report on Friday, April 16th. Finally, Argus dropped their price objective on The Clorox from $230.00 to $206.00 and set a “buy” rating for the company in a report on Friday, May 21st. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have given a buy rating to the stock. The Clorox has an average rating of “Hold” and a consensus price target of $207.94.

About The Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands.

Recommended Story: Ex-Dividend

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.